In-Vivo Antibodies Targeting Tumor-Specific Antigens in Cancer Research

by | Jul 10, 2024 | Cancer, Immunology, in vivo Studies, Neurology

IN VIVO ANTIBODIES FROM BIO X CELL

In-Vivo Antibodies Targeting Tumor-Specific Antigens in Cancer Research

Tumor antigens are proteins expressed on the surface of tumor cells or secreted into the bloodstream. Tumor antigens have been identified for most human cancers. There are two major classes of tumor antigens. Tumor-specific antigens (TSA), are found only on cancer cells, not on healthy cells and tumor-associated antigens (TAA), which are highly expressed on tumor cells, but are also expressed at lower levels on healthy cells. 

Bio X Cell offers several antibodies specific for tumor antigens which can be used in cancer research.

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

ABOUT BIO X CELL

Antibodies For In Vivo Research

Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.

 

    • Exceptional Purity
    • Pathogen Free
    • Ultra-low Endotoxin Level
    • Advanced Binding Validation
    • Low Protein Aggregation
    • Marching Isotype Control Antibodies

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

Learn more on our comprehensive in-vivo research reagents today.

Contact us
Share This